Abstract
Scales and behavioral tests are the primary source of data in human research for measuring, modeling, and testing perception, thoughts, feelings, complains, and performance. In drug development scales and tests are used in clinical trials as tools to support diagnosis; evaluate states and traits, as well as lifestyle and performance of patients; or collect ratings by relatives and health carers before, during, and after treatment. Clinical scales can be classified according to several criteria; one classification is according to the intended responder and the method of data generation (FDA 2016; Walton et al. Value Health 18:741–752, 2015). Well-developed and ready-for-purpose scales and tests can be used to describe, characterize, or quantify (localize) objects and processes within a framework of a pharmacological clinical study or preferably of a drug development program of interest. In the present article the conceptualization, development, selection, analysis, and application of items and scales in various phases of clinical drug development are presented in an overview and discussed.
References and Further Reading
Acquadro C, Jambon B, Ellis D, Marquis P (1996) Language and translation issues. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven, Philadelphia, pp 575–585
Agresti A (1996) An introduction to categorical data analysis. Wiley, New York
AMDP&CIPS (1990) Rating scales for psychiatry, European edn. Beltz Test GmbH, Weinheim
APA (American Psychiatric Association) (2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. American Psychiatric Association, Washington, DC
APA (American Psychological Association) (2014) Standards for educational and psychological testing. American Educational Research Association, Washington, DC. http://www.apa.org/science/programs/testing/standards.aspx
Asadi-Lari M, Tamburini M, Gray D (2004) Patients’ needs, satisfaction, and health related quality of life: towards a comprehensive model. Health Qual Life Outcomes 2:32
Biel V. Big data analytics. http://www.webopedia.com/TERM/B/big_data_analytics.html
Bland JM, Altman DG (1996) Measurement error and correlation coefficients. Br J Med 313:41–42
Borg I, Groenen P (2005) Modern multidimensional scaling: theory and applications, 2nd edn. Springer, New York. 2nd edn. Washington, DC: American Council on Education
Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37–46
Cohen J (1968) Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70:213–220
Cohen J (1977) Statistical power analysis for the behavioural sciences, revth edn. Academic, New York
Committee for Medicinal Products for Human Use (2005) Reflection paper on the regulatory guidance for the use of Health-Related Quality of Life (HRQL) measures in the evaluation of medicinal products. EMEA, London
Cronbach LJ (1971) Test validation. In: Thorndike RL (ed) Educational measurement. American Council on Education, Washington, DC, pp 443–507
Cronbach LJ (2004) My current thoughts on coefficient alpha and successor procedures. Educ Psychol Meas 64:391–418
Cronbach LJ, Meehl PE (1955) Construct validity in psychological tests. Psychol Bull 52:281–302
EMEA (2007) Innovative drug development approaches, EMEA/127318/2007. EMEA, London
Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol Bull 76(5):378–382
Fleiss JL (1981) Statistical methods for rates and proportions, 2nd edn. Wiley, New York, pp 38–46
Fleiss JL, Cohen J (1973) The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 33:613–619
Food and Drug Administration (2000) Title 21 Code of Federal Regulations (21 CFR Part 11) Electronic Records; Electronic Signatures. http://www.fda.gov/ora/compliance_ref/Part11/
Food and Drug Administration (2006). Guidance for industry, patient-reported outcome measures: use in medical product development to support labeling claims, Silver Spring
Food and Drug Administration (2009) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed 3 Jan 2017
Food and Drug Administration (2016) Clinical outcome assessment (COA): glossary of terms. Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm370262.htm. Accessed 3 Jan 2017
Food and Drug Administration (2017) Clinical outcome assessment qualification program. https://www.fda.gov/drugs/developmentapprovalprocess/drugdevelopmenttoolsqualificationprogram/ucm284077.htm. Page Last Updated: 06 Aug 2017
Gartner IT. Glossary. https://research.gartner.com/definition-whatis-big-data?resId=3002918&srcId=1-8163325102
Guilford JP (1946) New standards for test evaluation. Educ Psychol Meas 6(5):427–439
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Kahneman D (2011) Thinking, fast and slow. Farrar, Straus and Giroux, New York
Kelly P (2015) Electronic questionnaires at statistics Canady. https://wwwn.cdc.gov/qbank/QUest/2015/s423-paul_kelly_quest2015.pdf
Kendell R, Jablensky A (2003) Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 160(1):4–12
Kundel HL, Nodine CF, Conant EF, Weinstein SP (2007) Holistic component of image perception in mammogram interpretation: gaze-tracking study. Radiology 242:396–402
Lienert GA, Raatz V (1998) Testaufbau und Testanalyse. Weinheim, Psychologie Verlags Union 1998 (6. Aufl)
Linden WJ, van der Hambleton RK (1997) Handbook of modern item response theory. Springer, New York
Little RJA, Rubin DB (1987) Statistical analysis with missing data. Wiley, New York
Messick S (1989) Validity. In: Linn R (ed) Educational measurement, 3rd edn. American Council on Education and Macmillan, New York, pp 13–103
Middel B, van Sonderen E (2002) Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int J Integ Care 2.:2002:e15
NASA Report. ftp://ftp.hq.nasa.gov/pub/pao/reports/1999/MCO_report.pdf
National Institute of Mental Health. Research priorities. NIMH page on RDoC. http://www.nimh.nih.gov/research-priorities/rdoc/index.shtml
Obuchowski NA (2005) ROC analysis. Am J Roentgenol 184:364–372
Osgood CE, Suci G, Tannenbaum P (1957) The measurement of meaning. University of Illinois Press, Urbana
Patrick DL et al (2007) Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 10(Supplement 2):S125–S137
Powers JH, Patrick DL, Walton MK, Marquis P, Cano S, Hobart J, Isaac M, Vamvakas S, Slagle A, Molsen E, Burke LB (2017) Clinician-reported outcome assessments of treatment benefit: report of the ISPOR clinical outcome assessment emerging good practices task force. Value Health 20(1):2–14. https://doi.org/10.1016/j.jval.2016.11.005
Rasch G (1960) Probabilistic models for some intelligence and achievement tests. Danish Institute for Educational Research (expanded edition), 1980, Copenhagen. University of Chicago Press, Chicago
Rost J (2004) Lehrbuch Testtheorie – Testkonstruktion. Huber, Bern (2. Aufl)
Schadow G, McDonald CJ (2014) The unified code for units of measure. Regenstrief Institute, Inc. and the UCUM Organization 1988–2014. http://unitsofmeasure.org/ucum.html
Schwarz N (1999) Self-reports. How questions shape the answer. Am Psychol 54(2):93–105
Stevens SS (1951) Mathematics, measurement and psychophysics. In: Stevens SS (ed) Handbook of experimental psychology. Wiley, New York, pp 1–49
Thompson B (ed) (2003) Score reliability: contemporary thinking on reliability issues. Sage, Thousand Oaks
Walton MK, Powers JH III, Hobart J et al (2015) Clinical outcome assessments: conceptual foundation: report of the ISPOR clinical outcomes assessment – emerging good practices for outcomes research task force. Value Health 18:741–752
Wild D, Eremenco S, Mear I, Martin M, Houchin C, Gawlicki M, Hareendran A, Wiklund I, Chong LY, von Maltzahn R, Cohen L, Molsen E (2009) Multinational trials – recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report. Value Health 12(4.) 2009):430
Wilke RJ, Burke LB, Erickson P (2004) Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved labels. Control Clin Trials 25:535–552
William HL, Conway MA, Cohen G (2008) Autobiographical memory. In: Cohen G, Conway M (eds) Memory in the real world, 3rd edn. Psychology Press, Hove
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Görtelmeyer, R. (2017). Methodologies of PD Assessment: Scales. In: Hock, F., Gralinski, M. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_27-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56637-5_27-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56637-5
Online ISBN: 978-3-319-56637-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences